Health & Wellbeing
2025 Free
Ovarian Cancer Action

Annual Report 2024–25

Ovarian Cancer Action has been at the heart of global ovarian cancer research for 40 years. Their 2024/25 annual report highlights major strides including the development of the world's first ovarian cancer vaccine, the launch of a new Global Research Consortium, and a high-profile Coronation Street partnership to raise symptom awareness. Their goal is for 50% of women to survive more than 10 years after diagnosis by 2032.

View Report
Report snapshot
98 Views

About

Ovarian Cancer Action Research Centre; Helene Harris Memorial Trust (HHMT) International Forum; Global Ovarian Cancer Research Consortium ($1m AI grant); Patient Research Network; OvarianVax vaccine development (University of Oxford); symptom awareness campaigns; Coronation Street partnership; BRCA community outreach Custom geography from upload: UK

Key Metrics

Key Metric 1 264,000 people accessed the OCA website in 2024/25
Key Metric 2 Nearly 200,000 people reached through Ovarian Cancer Awareness Month campaign
Key Metric 3 Over 10,000 people completed the genetic risk tool

Key Outcomes

  • World-first ovarian cancer vaccine (OvarianVax) development unlocked, with Cancer Research UK funding secured; potential to move to human clinical trials within five years
  • Global Ovarian Cancer Research Consortium established with leading charities in USA, Australia and Canada, including a $1 million AI research grant
  • Coronation Street partnership drove over 100,000 visits to symptom pages and reached millions through digital campaigns and major media coverage

Geography

Other

Related reports

All Health & Wellbeing reports →
DEBRA UK

Impact — Winter 2026

2026 Enhanced
Impact Snapshot
Key Metric 1
Total income £18,180,000 and total expenditure £18,560,000 (year ended 31 December 2024, charity no. 1084958 England/Wales and SC039654 Scotland); in 2024 spent £3.8m on...
Key Metric 2
700+ members supported through in-person visits and support calls in 2025; 697 support grants allocated in 2025 for essential items including specialist clothing, cooling...
Key Metric 3
Largest global investment in EB research to date: multi-million-pound drug repurposing trial provisionally agreed with LifeArc partner at Guy's and St Thomas' NHS Foundation...
£34,000 raised in 2025 winter appeal supporting families like Darcie's with specialist items, emotional support and research; 697 support grants delivered in 2025; first Members Connect event in Northern Ireland; EB Priorities Setting Partnership study completed providing global research roadmap
Health & Wellbeing Disability
Read report
The Royal British Legion

Impact Report 2025

2025 Enhanced
Impact Snapshot
Key Metric 1
22,507 households helped through RBL casework and specialist support services across 66 countries
Key Metric 2
22,600 grants given to those in need, totalling £11.8 million
Key Metric 3
733 beneficiaries represented at tribunals, resulting in £24.5 million in War Pensions awards
1,548 new families living with dementia supported by RBL Admiral Nurses service
Health & Wellbeing Dementia
Read report
Blind Veterans UK

Our Impact 2024-25

2025 Enhanced
Impact Snapshot
Key Metric 1
3,600 blind veterans received support across the UK; 447 new blind veterans started receiving support in 2024/25
Key Metric 2
1,598 referrals to rehabilitation services completed; 313 veterans received assistive technology training
Key Metric 3
997 volunteers donated 26,824 hours of support; befriending service awarded Quality in Befriending Excellence — one of only 11 organisations in the UK to...
1,831 National Creative Wellbeing Project packs issued to help veterans reconnect with creativity and independence
Health & Wellbeing Wellbeing
Read report
Diabetes UK

Annual Report and Accounts 2024

2024 Enhanced
Impact Snapshot
Key Metric 1
349,000+ people completed the Know Your Risk tool to assess their risk of type 2 diabetes in 2024
Key Metric 2
£4 million invested in 17 new research projects; total active grants portfolio worth over £45 million
Key Metric 3
32% of people completing NHS England's Path to Remission programme — which Diabetes UK campaigned for — put their type 2 diabetes into remission
Type 1 Diabetes Grand Challenge invested over £23 million in 19 projects across 161 experts from 47 institutions in 8 countries since 2022
Health & Wellbeing Research
Read report